Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid LeukemiaPinkal Desai, Farhad Ravandi, Luke P. Akard et al.|Journal of Clinical Oncology|2021Cited by 21
A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.Camille N. Abboud, Farhad Ravandi, Luke P. Akard et al.|Journal of Clinical Oncology|2018Cited by 3